We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Department of Anesthesiology

You are here


[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Schillers H, Rianna C, Schäpe J, Luque T, Doschke H, Wälte M, Uriarte JJosé, Campillo N, Michanetzis GPA, Bobrowska J et al..  2017.  Standardized Nanomechanical Atomic Force Microscopy Procedure (SNAP) for Measuring Soft and Biological Samples.. Sci Rep. 7(1):5117.
Schenck EJ, Hoffman K, Goyal P, Choi J, Torres L, Rajwani K, Tam CW, Ivascu N, Martinez FJ, Berlin DA.  2020.  Respiratory Mechanics and Gas Exchange in COVID-19 Associated Respiratory Failure.. Ann Am Thorac Soc.
Scharoun JH, Han JH, Y Gobin P.  2017.  Anesthesia for Ophthalmic Artery Chemosurgery.. Anesthesiology. 126(1):165-172.
Savarese JJ, Belmont MR, Hashim MA, Mook RA, Boros EE, Samano V, Patel SS, Feldman PL, Schultz J-AI, McNulty M et al..  2004.  Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium.. Anesthesiology. 100(4):835-45.
Savarese JJ.  1986.  Clinical relaxation: current controversy.. Can Anaesth Soc J. 33(3 Pt 2):S1-4.
Savarese JJ.  1979.  The autonomic margins of safety of metocurine and d-tubocurarine in the cat.. Anesthesiology. 50(1):40-6.
Savarese JJ, Lien CA, Belmont MR.  1995.  The accuracy of the 5%-25% (T1-T3) twitch recovery interval in predicting the speed of spontaneous recovery from mivacurium-induced neuromuscular blockade.. Anesth Analg. 80(1):209-10.
Savarese JJ, Kitz RJ.  1973.  The quest for a short-acting nondepolarizing neuromuscular blocking agent.. Acta Anaesthesiol Scand Suppl. 53:43-58.
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
Savarese JJ.  1981.  The new neuromuscular blocking drugs are here.. Anesthesiology. 55(1):1-3.
Savarese JJ.  1975.  Letter: Histamine, d-tubocurarine, and CSF pressure.. Anesthesiology. 42(3):369.
Savarese JJ, Ginsburg S, Braswell L, Kitz RJ.  1979.  Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.. J Pharmacol Exp Ther. 208(3):436-45.
Savarese JJ, Lien CA, Belmont MR, Rubin L.  1995.  The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.. Acta Anaesthesiol Scand Suppl. 106:18-22.
Savarese JJ, Ginsburg S, Lee SM, Kitz RJ.  1973.  The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications.. Anesth Analg. 52(6):982-8.
Savarese JJ, Wastila WB.  1995.  The future of the benzylisoquinolinium relaxants.. Acta Anaesthesiol Scand Suppl. 106:91-3.
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Savarese JJ, Kitz RJ.  1975.  Does clinical anesthesia need new neuromuscular blocking agents? Anesthesiology. 42(3):236-9.
Savarese JJ, Goldenheim PD, Thomas GB, Kaiko RF.  1986.  Steady-state pharmacokinetics of controlled release oral morphine sulphate in healthy subjects.. Clin Pharmacokinet. 11(6):505-10.
Savarese JJ, Philbin DM.  1979.  Cardiovascular effects of neuromuscular blocking agents.. Int Anesthesiol Clin. 17(1):13-54.
Savarese JJ, Lien CA, Belmont MR.  1996.  Antagonism of residual mivacurium blockade: setting the record straight.. Anesthesiology. 84(6):1525-8.
Savarese JJ, Todd D.  1973.  Letter: Succinylcholine effects in anesthesia.. JAMA. 226(11):1359-60.
Savarese JJ, McGilvra JD, Sunaga H, Belmont MR, Van Ornum SG, Savard PM, Heerdt PM.  2010.  Rapid chemical antagonism of neuromuscular blockade by L-cysteine adduction to and inactivation of the olefinic (double-bonded) isoquinolinium diester compounds gantacurium (AV430A), CW 002, and CW 011.. Anesthesiology. 113(1):58-73.
Savarese JJ, Brinken BW, Zaleske DJ.  1995.  Epiphyseal replacement in a murine model.. J Pediatr Orthop. 15(5):682-90.
Savarese JJ, Antonio RP, Ginsburg S.  1975.  Potential clinical uses of short-acting nondepolarizing neuromuscular-blocking agents as predicted from animal experiments.. Anesth Analg. 54(5):669-78.
Savarese JJ, Thomas GB, Homesley H, Hill CS.  1988.  Rescue factor: a design for evaluating long-acting analgesics.. Clin Pharmacol Ther. 43(4):376-80.